Leukemia & Lymphoma, Volume 47, Issue 11 (2006)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 47, Issue 11 (2006)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Volume 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary

Article Commentary
Prognostic factors in chronic lymphocytic leukemia
Terry Hamblin
Pages: 2261-2262
Published online: 01 Jul 2009
CitationforPrognostic factors in chronic lymphocytic leukemia | Full Text | References | PDF (51.6 KB)
  • 31 Views
  • 5 CrossRef citations
  • 0Altmetric
Article Commentary
Multi-drug resistance in B-cell chronic lymphocytic leukemia (B-CLL): A feature of B-CLL sub-sets with poor prognosis genetic alterations?
Andreas Rosenwald MD
Pages: 2263-2264
Published online: 01 Jul 2009
CitationforMulti-drug resistance in B-cell chronic lymphocytic leukemia (B-CLL): A feature of B-CLL sub-sets with poor prognosis genetic alterations? | Full Text | References | PDF (49.9 KB)
  • 32 Views
  • 2 CrossRef citations
  • 0Altmetric
Article Commentary
Second neoplasms in chronic lymphocytic leukemia: Are case-group studies useful?
Stefano Molica
Pages: 2265-2266
Published online: 01 Jul 2009
CitationforSecond neoplasms in chronic lymphocytic leukemia: Are case-group studies useful? | Full Text | References | PDF (51.6 KB)
  • 26 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
The role of anthracyclines in follicular lymphomas
Stefano Luminari & Massimo Federico
Pages: 2267-2268
Published online: 01 Jul 2009
CitationforThe role of anthracyclines in follicular lymphomas | Full Text | References | PDF (53.5 KB)
  • 23 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
HFE H63D variant and leukemia susceptibility
M. Tevfik Dorak MD, PhD
Pages: 2269-2270
Published online: 01 Jul 2009
CitationforHFE H63D variant and leukemia susceptibility | Full Text | References | PDF (53.9 KB)
  • 62 Views
  • 12 CrossRef citations
  • 0Altmetric
Article Commentary
Is there still place for VAD as primary treatment for patients with multiple myeloma who are candidates for high-dose therapy?
Meletios A. Dimopoulos & Efstathios Kastritis
Pages: 2271-2272
Published online: 01 Jul 2009
CitationforIs there still place for VAD as primary treatment for patients with multiple myeloma who are candidates for high-dose therapy? | Full Text | References | PDF (54 KB)
  • 37 Views
  • 5 CrossRef citations
  • 0Altmetric
Article Commentary
Myeloma, thalidomide and thrombosis
Dirk Hönemann & H. Miles Prince
Pages: 2273-2275
Published online: 01 Jul 2009
First Page PreviewforMyeloma, thalidomide and thrombosis | Full Text | References | PDF (59.8 KB)
  • 35 Views
  • 5 CrossRef citations
  • 0Altmetric
Article Commentary
The troublesome toxicity of peripheral neuropathy with thalidomide
Linda Mileshkin & H. Miles Prince
Pages: 2276-2279
Published online: 01 Jul 2009
First Page PreviewforThe troublesome toxicity of peripheral neuropathy with thalidomide | Full Text | References | PDF (68.1 KB)
  • 197 Views
  • 22 CrossRef citations
  • 0Altmetric
Article Commentary
A role for aberrant Notch signaling in acute myeloid leukemia?
Marc R. Mansour
Pages: 2280-2281
Published online: 01 Jul 2009
CitationforA role for aberrant Notch signaling in acute myeloid leukemia? | Full Text | References | PDF (51.8 KB)
  • 45 Views
  • 0 CrossRef citations
  • 0Altmetric

Original

Article
Optimizing treatment for elderly patients with acute promyelocytic leukemia: is it time to replace chemotherapy with all-trans retinoic acid and arsenic trioxide?
Apostolia-Maria Tsimberidou, Hagop Kantarjian, Michael J. Keating & Elihu Estey
Pages: 2282-2287
Published online: 01 Jul 2009
AbstractforOptimizing treatment for elderly patients with acute promyelocytic leukemia: is it time to replace chemotherapy with all-trans retinoic acid and arsenic trioxide? | Full Text | References | PDF (395.9 KB)
  • 159 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Ten years and counting: so what do we know about t(4;14)(p16;q32) multiple myeloma
Jonathan J. Keats, Tony Reiman, Andrew R. Belch & Linda M. Pilarski
Pages: 2289-2300
Published online: 01 Jul 2009
AbstractforTen years and counting: so what do we know about t(4;14)(p16;q32) multiple myeloma | Full Text | References | PDF (322.8 KB)
  • 505 Views
  • 73 CrossRef citations
  • 0Altmetric
Article
2-CdA in the treatment of hairy cell leukemia: a review of long-term follow-up
Adi Gidron & Martin S. Tallman
Pages: 2301-2307
Published online: 01 Jul 2009
Abstractfor2-CdA in the treatment of hairy cell leukemia: a review of long-term follow-up | Full Text | References | PDF (261.1 KB)
  • 228 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
MDR-1, but not MDR-3 gene expression, is associated with unmutated IgVH genes and poor prognosis chromosomal aberrations in chronic lymphocytic leukemia
Christine Matthews, Mark A. Catherwood, Anne-Marie Larkin, Martin Clynes, Tcm ‘Curly’ Morris & H. Denis Alexander FRCPath DPhil
Pages: 2308-2313
Published online: 01 Jul 2009
AbstractforMDR-1, but not MDR-3 gene expression, is associated with unmutated IgVH genes and poor prognosis chromosomal aberrations in chronic lymphocytic leukemia | Full Text | References | PDF (211.5 KB)
  • 78 Views
  • 43 CrossRef citations
  • 0Altmetric
Article
Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy
Vincenzo Callea, Maura Brugiatelli, Caterina Stelitano, Massimo Gentile, Francesco Nobile & Fortunato Morabito
Pages: 2314-2320
Published online: 01 Jul 2009
AbstractforIncidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy | Full Text | References | PDF (245.6 KB)
  • 164 Views
  • 23 CrossRef citations
  • 0Altmetric
Article
The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial
P. R. A. Taylor, J. M. White, R. J. Prescott, B. Angus, M. J. Galloway, G. H. Jackson, A. M. Lessells, H. H. Lucraft, G. P. Summerfield, S. J. Proctor & On Behalf Of The Scotland and Newcastle Lymphoma Group
Pages: 2321-2330
Published online: 01 Jul 2009
AbstractforThe addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial | Full Text | References | PDF (623.2 KB)
  • 85 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
HFE gene mutations in patients with acute leukemia
Assunta Viola, Leonilde Pagano, Daniela Laudati, Rossella D'elia, Maria Rosaria D'amico, Massimiliano Ammirabile, Salvatore Palmieri, Luciano Prossomariti & Felicetto Ferrara
Pages: 2331-2334
Published online: 01 Jul 2009
AbstractforHFE gene mutations in patients with acute leukemia | Full Text | References | PDF (70.3 KB)
  • 78 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
The combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide – vincristine – doxorubicin – methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case-matched analysis
Ping Wu, Faith E. Davies, Clive Horton, Matthew W. Jenner, Biju Krishnan, Caroline L. Alvares, Radovan Saso, Rita Mccormack, Sharon Dines, Jennifer G. Treleaven, Michael N. Potter, Mark E. Ethell & Gareth J Morgan
Pages: 2335-2338
Published online: 01 Jul 2009
AbstractforThe combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide – vincristine – doxorubicin – methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case-matched analysis | Full Text | References | PDF (72.2 KB)
  • 180 Views
  • 37 CrossRef citations
  • 0Altmetric
Article
Prospective evaluation of low-dose warfarin for prevention of thalidomide associated venous thromboembolism
Kena C. Miller, Swaminathan Padmanabhan, Laurie Dimicelli, Dawn Depaolo, Beverly Landrigan, Jihnhee Yu, Virginia Doran, Patricia Marshal & Asher Chanan-Khan
Pages: 2339-2343
Published online: 01 Jul 2009
AbstractforProspective evaluation of low-dose warfarin for prevention of thalidomide associated venous thromboembolism | Full Text | References | PDF (78.2 KB)
  • 125 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphoma
Max Wolf, Mark Bentley, Paula Marlton, Noemi Horvath, Ian D. Lewis, Andrew Spencer, Richard Herrmann, Chris Arthur, Simon Durrant, Marilyn van Kerkhoven, Jamie Macmillan & Robert Mrongovius
Pages: 2344-2350
Published online: 01 Jul 2009
AbstractforPegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphoma | Full Text | References | PDF (353.7 KB)
  • 124 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
Clonal lymphocytic populations in Philadelphia-negative chronic myeloproliferative disorders: is the T-cell clonality of ‘undetermined’ significance (TCUS) linked to a worse clinical outcome?
Anastazja Stój, Zbigniew Rudzki, Danuta Piniewska, Tomasz Sacha, Sylwia Czekalska, Krzysztof Okoń & Jerzy Stachura
Pages: 2351-2358
Published online: 01 Jul 2009
AbstractforClonal lymphocytic populations in Philadelphia-negative chronic myeloproliferative disorders: is the T-cell clonality of ‘undetermined’ significance (TCUS) linked to a worse clinical outcome? | Full Text | References | PDF (143.7 KB)
  • 54 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Chromosomal imbalances in pediatric Burkitt-like lymphoma and review of the literature in relation to other germinal center derived B-cell tumors
Annalisa Pezzolo PhD, Roberta Cinti, Francesca Negri, Federica Parodi, Alberto Garaventa, Claudio Gambini & Vito Pistoia
Pages: 2359-2364
Published online: 01 Jul 2009
AbstractforChromosomal imbalances in pediatric Burkitt-like lymphoma and review of the literature in relation to other germinal center derived B-cell tumors | Full Text | References | PDF (318.9 KB)
  • 66 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Incidence rates of the major leukemia subtypes among U.S. Hispanics, Blacks, and non-Hispanic Whites
Matthew J. Matasar, Ellen K. Ritchie, Nathan Consedine, Carol Magai & Alfred I. Neugut
Pages: 2365-2370
Published online: 01 Jul 2009
AbstractforIncidence rates of the major leukemia subtypes among U.S. Hispanics, Blacks, and non-Hispanic Whites | Full Text | References | PDF (322.6 KB)
  • 393 Views
  • 54 CrossRef citations
  • 0Altmetric
Article
CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia
Amjad Hayat, David O'Brien, Paul O'Rourke, Siobhan McGuckin, Tony Fitzgerald, Eibhlin Conneally, Paul V. Browne, Shaun R. Mccann, Mark P. Lawler & Elisabeth Vandenberghe
Pages: 2371-2379
Published online: 01 Jul 2009
AbstractforCD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia | Full Text | References | PDF (701.3 KB)
  • 98 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
Anti-CD19 immunotoxin enhances the activity of chemotherapy in severe combined immunodeficient mice with human pre-B acute lymphoblastic leukemia
L. Herrera, C. Stanciu-Herrera, C. Morgan, V. Ghetie & E. S. Vitetta
Pages: 2380-2387
Published online: 01 Jul 2009
AbstractforAnti-CD19 immunotoxin enhances the activity of chemotherapy in severe combined immunodeficient mice with human pre-B acute lymphoblastic leukemia | Full Text | References | PDF (399.3 KB)
  • 79 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Characterization of antibody-containing vesicles shed from B-lymphoma cell lines: exposure of annexin V binding sites
Rosana B. Michel, Mones Abu-Asab, Maria Tsokos & M. Jules Mattes
Pages: 2388-2399
Published online: 01 Jul 2009
AbstractforCharacterization of antibody-containing vesicles shed from B-lymphoma cell lines: exposure of annexin V binding sites | Full Text | References | PDF (1.2 MB)
  • 31 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
NOTCH1 mutations are rare in acute myeloid leukemia
Lu Fu, Hanae Kogoshi, Nobuo Nara & Shuji Tohda MD
Pages: 2400-2403
Published online: 01 Jul 2009
AbstractforNOTCH1 mutations are rare in acute myeloid leukemia | Full Text | References | PDF (250.8 KB)
  • 186 Views
  • 16 CrossRef citations
  • 0Altmetric

Miscellaneous

Case 31: Eosinophilia and pruritus
V. Jayakar, R. D. Goldin & Barbara J. Bain
Pages: 2404-2405
Published online: 01 Jul 2009
AbstractforCase 31: Eosinophilia and pruritus | Full Text | References | PDF (344.8 KB)
  • 71 Views
  • 4 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Lymphoplasmacytic lymphoma presenting as malignant ascites
Becky van Ells & John Lazarchick
Pages: 2406-2408
Published online: 01 Jul 2009
First Page PreviewforLymphoplasmacytic lymphoma presenting as malignant ascites | Full Text | References | PDF (476.8 KB)
  • 27 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
The efficacy of low dose thalidomide in refractory/relapsed myeloma—a retrospective audit
G. Cherian, D. W. Thomas & S. A. J. Rule
Pages: 2409-2411
Published online: 01 Jul 2009
First Page PreviewforThe efficacy of low dose thalidomide in refractory/relapsed myeloma—a retrospective audit | Full Text | References | PDF (56.9 KB)
  • 42 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Can survivin expression predict the response to bortezomib in cases with mantle cell lymphoma?
Semra Paydas
Pages: 2412-2413
Published online: 01 Jul 2009
CitationforCan survivin expression predict the response to bortezomib in cases with mantle cell lymphoma? | Full Text | References | PDF (52.7 KB)
  • 49 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Megakaryoblastic differentiation of myeloid sarcoma in a patient with essential thrombocythemia
Graziana Famoso, Maurilio Ponzoni MD, Massimo Freschi, Fina Lo Cunsolo, Moreno Tresoldi, Gabriele di Comite & Claudio Doglioni
Pages: 2414-2417
Published online: 01 Jul 2009
First Page PreviewforMegakaryoblastic differentiation of myeloid sarcoma in a patient with essential thrombocythemia | Full Text | References | PDF (557 KB)
  • 105 Views
  • 10 CrossRef citations
  • 0Altmetric
Letter
Bilateral thalamic infarction after reinfusion of DMSO-preserved autologous stem-cells
Suna Hentschke, Moritz Hentschke, Kornelia Hummel, Hans J. Salwender, Dietrich Braumann & Axel Stang
Pages: 2418-2420
Published online: 01 Jul 2009
First Page PreviewforBilateral thalamic infarction after reinfusion of DMSO-preserved autologous stem-cells | Full Text | References | PDF (201.2 KB)
  • 57 Views
  • 8 CrossRef citations
  • 0Altmetric
Letter
Characteristics and outcome of B-cell chronic lymphocytic leukemia in hepatitis C virus-positive patients
Stefano Molica, Rosanna Mirabelli & Demetrio Misuraca
Pages: 2421-2423
Published online: 01 Jul 2009
First Page PreviewforCharacteristics and outcome of B-cell chronic lymphocytic leukemia in hepatitis C virus-positive patients | Full Text | References | PDF (119.1 KB)
  • 70 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Hepatocellular carcinoma with indolent T-lymphoblastic proliferation
Zhao-Ming Wang, Wen-Bo Xiao, Shu-Sen Zheng, Ke Sun & Li-Jun Wang
Pages: 2424-2426
Published online: 01 Jul 2009
First Page PreviewforHepatocellular carcinoma with indolent T-lymphoblastic proliferation | Full Text | References | PDF (369.6 KB)
  • 110 Views
  • 14 CrossRef citations
  • 0Altmetric
Letter
Imatinib mesylate-induced long-term remission in extra-medullary T-cell lymphoid blastic phase of chronic myelogenous leukemia
Jan A. Burger MD, Annette Schmitt-Gräff, Andrea Bürkle, Lysann Seiler & Jürgen Finke
Pages: 2427-2430
Published online: 01 Jul 2009
First Page PreviewforImatinib mesylate-induced long-term remission in extra-medullary T-cell lymphoid blastic phase of chronic myelogenous leukemia | Full Text | References | PDF (744.9 KB)
  • 28 Views
  • 2 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles